Literature DB >> 4331798

Renin activation in the venous plasma from the involved kidney in the patient with renal hypertension.

M P Sambhi, C E Wiedeman.   

Abstract

Measurements of plasma renin activity (PRA) in renal vein blood from the ischemic kidney are reported to be generally higher than from the contralateral kidney. Importance of factors other than renin content of renal venous plasma has not been investigated. Initial rate measurements of angiotensin generation with added excess of homologous renin (Plasma Renin Substrate Activity [PRSA]-20 min) were made in bilateral renal venous plasma from 31 patients suspected of suffering from unilateral renal hypertension. The mean values from the involved vs. the contralateral kidney were 551 vs. 331 ng respectively of angiotensin II equivalents generated per milliliter of plasma per 20 min of incubation. The measurement of maximal angiotensin generation under the same conditions with incubation prolonged to 3 hr (PRSA-180 min), however, were bilaterally equal in renal venous plasma from selected patients with renal hypertension who showed distinct differences in PRSA-20 min and PRA measurements. Prior extraction of plasma lipids did not significantly change the bilateral renal venous PRSA-20 min determinations. Stimulation of endogenous renin release in normal dogs did not change the PRSA determinations. The data suggest strongly the presence of a "renin activating" mechanism in the renal venous plasma from the involved kidney of patients with renal hypertension.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4331798      PMCID: PMC332924          DOI: 10.1172/JCI106792

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Prognostic value of plasma renin activity in renovascular hypertension.

Authors:  P Meyer; J Ecoiffier; J M Alexandre; C Devaux; L Guize; J Menard; P Biron; P Milliez
Journal:  Circulation       Date:  1967-10       Impact factor: 29.690

2.  Isolation of a phospholipid renin inhibitor from kidney.

Authors:  S Sen; R R Smeby; F M Bumpus
Journal:  Biochemistry       Date:  1967-06       Impact factor: 3.162

3.  Chemical assay of phospholipid renin preinhibitor in canine and human blood.

Authors:  D Ostrovsky; S Sen; R R Smeby; F M Bumpus
Journal:  Circ Res       Date:  1967-10       Impact factor: 17.367

4.  Development of tachyphylaxis to aspartyl and not asparginyl angiotensin II in the rat.

Authors:  M P Sambhi; J D Barrett
Journal:  Circ Res       Date:  1967-09       Impact factor: 17.367

5.  Extraction, purification, and assay of human renin free of angiotensinase.

Authors:  E Haas; H Goldblatt; E C Gipson; L Lewis
Journal:  Circ Res       Date:  1966-10       Impact factor: 17.367

6.  Measurement of renin and substrate concentrations in human serum.

Authors:  A B Gould; L T Skeggs; J R Kahn
Journal:  Lab Invest       Date:  1966-11       Impact factor: 5.662

7.  Measurement of renin activity in human plasma.

Authors:  P T Pickens; F M Bumpus; A M Lloyd; R R Smeby; I H Page
Journal:  Circ Res       Date:  1965-11       Impact factor: 17.367

8.  Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate.

Authors:  S L Skinner
Journal:  Circ Res       Date:  1967-04       Impact factor: 17.367

9.  Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension.

Authors:  A M Michelakis; J H Foster; G W Liddle; R K Rhamy; O Kuchel; R D Gordon
Journal:  Arch Intern Med       Date:  1967-10

10.  Renal venous renin determinations in the diagnosis of surgically correctable hypertension.

Authors:  A Fitz
Journal:  Circulation       Date:  1967-12       Impact factor: 29.690

View more
  1 in total

1.  Multiple forms of human plasma renin substrate.

Authors:  P Eggena; H Hidaka; J D Barrett; M P Sambhi
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.